Patient advocates and top national experts in trigeminal neuralgia, a chronic pain disorder that causes intense pain to the face, met at UF on March 7 and 8.
MBI Director Todd Golde, M.D., Ph.D., looks back at 2018 – a year that marked 20 years since our institute opened its doors – and shares his excitement about the future.
Following the passing of actor Luke Perry due to stroke, Dr. Brian Hoh discusses the signs, risk factors and prevalence of stroke, and his hope for future research and care.
British physicians cycling for a cause visited the McKnight Brain Institute on the final leg of their attempt to tandem cycle the world in record time.
Alcohol and Drug Addiction: The Gain in the Brain is in the Pain.
More than 100 brain tumor experts united at the inaugural ReMission Summit in Orlando with a mission to rewrite the story of brain cancer through collaboration and innovation.
See media highlights stemming from Feb. 22’s announcement of The Harris Rosen Foundation’s gift to advance brain tumor immunotherapy research at the MBI and launch the ReMission Alliance Against Brain Tumors.
A team led by Cara Croft, Ph.D., has demonstrated a novel method to model Alzheimer’s disease and Parkinson’s disease pathologies and seek potential therapeutic targets. Learn more: